Fredag 20 Mars | 17:20:35 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-08-14 22:05 Kvartalsrapport 2026-Q2
2026-05-22 N/A Årsstämma
2026-04-28 08:00 Bokslutskommuniké 2025
2026-03-13 - Extra Bolagsstämma 2026
2026-02-27 - Split ABTEC 50:1
2025-11-07 - Extra Bolagsstämma 2025
2025-08-27 - Kvartalsrapport 2025-Q2
2025-06-26 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2025-06-25 - Årsstämma
2025-05-02 - Bokslutskommuniké 2024
2024-11-13 - Extra Bolagsstämma 2024
2024-08-23 - Kvartalsrapport 2024-Q2
2024-07-01 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2024-06-28 - Årsstämma
2024-06-14 - Bokslutskommuniké 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-12 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2023-06-09 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-08-24 - Kvartalsrapport 2022-Q2
2022-06-10 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2022-06-09 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021
2021-08-25 - Kvartalsrapport 2021-Q2
2021-06-10 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2021-06-09 - Årsstämma
2021-04-30 - Bokslutskommuniké 2020
2020-09-11 - Extra Bolagsstämma 2020
2020-08-26 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2020-06-10 - Årsstämma
2020-04-15 - Bokslutskommuniké 2019
2019-08-28 - Kvartalsrapport 2019-Q2
2019-06-06 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2019-06-05 - Årsstämma
2019-04-24 - Bokslutskommuniké 2018
2019-01-07 - Extra Bolagsstämma 2019
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-30 - Årsstämma
2018-02-21 - Bokslutskommuniké 2017
2017-08-16 - Kvartalsrapport 2017-Q2
2017-06-08 - X-dag ordinarie utdelning ABTEC 1.00 NOK
2017-06-07 - Årsstämma
2017-02-15 - Bokslutskommuniké 2016
2016-11-18 - X-dag bonusutdelning ABTEC 1
2016-11-17 - 15-10 2016-Q3
2016-11-17 - Extra Bolagsstämma 2016
2016-08-17 - Kvartalsrapport 2016-Q2
2016-06-09 - X-dag ordinarie utdelning ABTEC 1.50 NOK
2016-06-08 - Årsstämma
2016-02-10 - Bokslutskommuniké 2015
2015-11-18 - Kvartalsrapport 2015-Q3
2015-08-19 - Kvartalsrapport 2015-Q2
2015-06-04 - X-dag ordinarie utdelning ABTEC 1.00 NOK
2015-06-03 - Årsstämma
2015-05-13 - Kvartalsrapport 2015-Q1
2015-02-11 - Bokslutskommuniké 2014
2014-11-26 - Kvartalsrapport 2014-Q3
2014-08-20 - Kvartalsrapport 2014-Q2
2014-06-11 - Årsstämma
2014-05-21 - Kvartalsrapport 2014-Q1
2014-02-12 - Bokslutskommuniké 2013
2013-11-27 - Kvartalsrapport 2013-Q3
2013-08-21 - Kvartalsrapport 2013-Q2
2013-06-13 - Kapitalmarknadsdag 2013
2013-06-12 - X-dag ordinarie utdelning
2013-06-11 - Årsstämma
2013-05-22 - Kvartalsrapport 2013-Q1
2013-02-13 - Bokslutskommuniké 2012
2012-11-27 - Kvartalsrapport 2012-Q3
2012-08-28 - Kvartalsrapport 2012-Q2
2012-06-14 - Årsstämma
2012-05-23 - Kvartalsrapport 2012-Q1
2012-02-17 - Bokslutskommuniké 2011
2011-11-30 - Kvartalsrapport 2011-Q3
2011-08-29 - Kvartalsrapport 2011-Q2
2011-06-17 - X-dag ordinarie utdelning
2011-06-16 - Årsstämma
2011-05-30 - Kvartalsrapport 2011-Q1
2011-02-18 - Bokslutskommuniké 2010

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriBioteknik
Aqua Bio Technology är ett norskt bolag verksamt inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom olika kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-20 15:20:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN

 

Reference is made to the stock exchange announcement by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 12 March 2026 regarding the start of the subscription period in a subsequent offering of up to 800,000 new shares (the "Offer Shares"), each at a subscription price of NOK 5.00 (the "Subsequent Offering").
 
The Subscription Period expired yesterday, 19 March 2026, at 16:30 hours (CET). The Company has been informed by our settlement agent that at the end of the Subscription Period, and based on a preliminary count, valid subscriptions had been received for a total of 388,240 Offer Shares.
 
The final result of the Subsequent Offering is expected to be announced by the Company on or about 23 March 2026. Investors that are allocated Offer Shares can access information on the number of Offer Shares allocated through VPS on or about 23 March 2026. Further announcements in respect of the Subsequent Offering and the Offer Shares will be made in due course.
 
The due date for payment of the Offer Shares is on 25 March 2026. Subject to due payment of the Offer Shares by the subscribers, the share capital increase relating to the Subsequent Offering will be registered with the Norwegian Register of Business Enterprises, and the Offer Shares will thereafter be delivered to the VPS accounts of the allocated subscribers on or about 8 April 2026. The Offer Shares will be delivered as listed and tradable shares. First day of trading of the Offer Shares on Euronext Expand is expected on or about 8 April 2026. A separate announcement will be made when the share capital increase has been registered.
 
 
IMPORTANT INFORMATION
 
This announcement is not an offer to sell or a solicitation of offers to purchase or subscribe for shares. Copies of this announcement may not be sent to jurisdictions, or distributed in or sent from jurisdictions, in which this is barred or prohibited by law. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful absent registration, or an exemption from registration or qualification under the securities laws of any jurisdiction.
 
This document is not for publication or distribution in, directly or indirectly, Australia, Canada, Japan, Hong Kong, South Africa or the United States or any other jurisdiction in which such release, publication or distribution would be unlawful, and it does not constitute an offer or invitation to subscribe for or purchase any securities in such countries or in any other jurisdiction. In particular, the document and the information contained herein should not be distributed or otherwise transmitted into the United States or to publications with a general circulation in the United States of America.
 
This announcement is not an offer for sale of securities in the United States. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Company does not intend to register any part of the offering in the United States or to conduct a public offering in the United States of the shares to which this document relates. This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company.
 
This announcement and any materials distributed in connection with this announcement may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
 
The Company expressly disclaims any obligation or undertaking to update, review or revise any statement contained in this announcement whether as a result of new information, future developments or otherwise.